Effects of insulin aspart (rdna origin) injection: A Synthesis of Findings from 6 Studies

  1. Home
  2. Effects of insulin aspart (rdna origin) injection
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of insulin aspart (rdna origin) injection: A Synthesis of Findings from 6 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of insulin aspart (rdna origin) injection: A Synthesis of Findings from 6 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Main Research Findings

Several studies have investigated the interaction between certain antifungal medications, including itraconazole and fluconazole, and the sedative drug midazolam. 3 These studies found that itraconazole and fluconazole can significantly increase the levels of midazolam in the body, potentially leading to enhanced sedative effects. 5 This interaction is more pronounced with oral midazolam than with intravenous midazolam. 4 Itraconazole has also been shown to be effective in treating fungal infections in patients with weakened immune systems, such as those with neutropenia. 1 , 2 Additionally, research suggests that combining terbinafine and itraconazole may provide improved treatment for fungal skin infections compared to using either drug alone. 6

Benefits and Risks

Benefits Summary

Itraconazole and fluconazole are effective antifungal medications for treating a variety of fungal infections. 3 , 5 , 6 , 4 , 1 , 2 In some cases, combining itraconazole with another antifungal medication, such as terbinafine, may provide better treatment outcomes. 6

Risks Summary

Itraconazole and fluconazole can interact with other medications, such as midazolam, increasing the risk of excessive sedation. 3 , 5 , 4 This interaction can be particularly significant when oral midazolam is used. 3 It is crucial to inform your doctor about all medications you are taking, including over-the-counter drugs and herbal supplements, to avoid potential drug interactions. 3 , 5 , 6 , 4 , 1 , 2

Comparison of Studies

Similarities of Studies

Several studies have focused on the interaction between itraconazole and other medications, highlighting the potential for drug interactions. 3 , 5 , 4 These studies emphasize the importance of considering drug interactions, especially when using medications like itraconazole that can affect the metabolism of other drugs.

Differences of Studies

Research has investigated various aspects of itraconazole's effects, including its interactions with specific drugs, its efficacy in treating fungal infections, and its potential use in combination therapies. 3 , 5 , 6 , 4 , 1 , 2 These studies have utilized different study designs, populations, and endpoints, providing a multifaceted understanding of itraconazole's properties.

Consistency and Contradictions in Results

Consistent findings across multiple studies indicate that itraconazole can significantly interact with other medications, particularly those metabolized by the same enzymes. 3 , 5 , 4 These interactions can alter the effects of these medications, potentially leading to unintended consequences.

Considerations for Real-Life Applications

When taking itraconazole, it is essential to be aware of potential drug interactions. 3 , 5 , 4 Discuss your medication history with your doctor to minimize the risk of unwanted interactions. 3 , 5 , 6 , 4 , 1 , 2

Limitations of Current Research

While research provides valuable insights into itraconazole's effects, further investigation is needed to fully understand its long-term implications and potential interactions with a wider range of medications. 3 , 5 , 6 , 4 , 1 , 2

Future Research Directions

Future research should delve deeper into the long-term effects and potential interactions of itraconazole with a wider range of medications, including those used in combination therapies. 3 , 5 , 6 , 4 , 1 , 2

Conclusion

Itraconazole is an effective antifungal medication, but it can interact with other medications, potentially leading to increased sedation. 3 , 5 , 6 , 4 , 1 , 2 It is crucial to discuss your medication history with your doctor to avoid potential drug interactions. 3 , 5 , 6 , 4 , 1 , 2 Always consult your doctor about any concerns or questions you have regarding your medication.

Literature analysis of 6 papers
Positive Content
2
Neutral Content
3
Negative Content
1
Article Type
6
0
0
0
6
1.

Itraconazole in neutropenic patients.

Author: van't WoutJ W

Fungal infection treatment
Itraconazole absorption

A study of 32 neutropenic patients with fungal infections compared the effectiveness of itraconazole and amphotericin B. Both treatments were effective against Candida infections, with 9 out of 16 patients responding to amphotericin B and 10 out of 16 responding to itraconazole. Itraconazole was more effective against Aspergillus infections, with 6 out of 8 patients responding compared to 2 out of 5 on amphotericin B. While amphotericin B treatment was associated with three deaths from Aspergillus infections, no deaths occurred in the itraconazole group. The study suggests that itraconazole may be a promising treatment for systemic fungal infections in neutropenic patients, although further research is needed.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

2.

[Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].

Author: van't WoutJ W, NovakovaI, VerhagenC A, FibbeW E, de PauwB E, van der MeerJ W

Effective against mycoses
Anaemia
Fever
Hypokalaemia
Hypotension
Nephrotoxicity
Renal tubular acidosis
Shivering
Side effects
Thrombocytopenia
Thrombophlebitis

A randomized comparative investigation was carried out to assess the efficacy of amphotericin B and itraconazole in the treatment of systemic mycoses in neutropenic patients.

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : German

3.

The effects of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.

Author: OlkkolaK T, AhonenJ, NeuvonenP J

Sedation
Increased midazolam effects

Itraconazole and fluconazole, azole antimycotics, significantly increased the effects of oral midazolam, raising its AUC and peak concentration by 3.5-fold and two-fold, respectively. This interaction also led to a profound increase in psychomotor effects. While the interaction with IV midazolam was weak, large doses of IV midazolam could still lead to clinically significant interactions. Using oral midazolam with itraconazole and fluconazole should be avoided.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

4.

The effect of ingestion time interval on the interaction between itraconazole and triazolam.

Author: NeuvonenP J, VarheA, OlkkolaK T

Increased triazolam effects

Itraconazole interacts considerably with triazolam when this hypnotic agent is ingested within 24 hours after itraconazole.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

5.

Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers.

Author: KrishnaGopal, MotonAllen, MaLei, SavantIshani, MartinhoMonika, SeiberlingMichael, McLeodJames

Drug interaction

This study aims to determine how the antifungal drug posaconazole affects the pharmacokinetic properties of midazolam, a short-acting benzodiazepine, due to their potential for drug interactions.

Clinical Trial, Phase IThe first stage of clinical trials in humans. Evaluates the safety, tolerability, and pharmacokinetics of a new drug/treatment.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

6.

Terbinafine Hydrochloride Combined With Itraconazole for Fungal Skin Diseases: A Randomized Controlled Trial.

Author: ZhangDongxing, LiaoWanqing, ChenCanhua, LaiHongtao, LiuShi

Combined therapy efficacy
Fungal skin diseases treatment

Combined treatment with terbinafine and itraconazole achieved better therapeutic effects in patients with fungal skin diseases compared to monotherapy. The combination group had significantly decreased symptom scores, a higher cure rate, and shorter cure time. No adverse events or relapses were reported during follow-up.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.